Stringent regulations and compliance standards set by global regulatory bodies have increased the compliance burden for companies. Additionally, the cost of analytical method development and validation combined with pressure to reduce drug development timelines and costs has made it difficult for labs to scale operations profitably. Finding skilled analytical chemists and maintaining aging testing equipment also impacts market players. Adopting newer technologies like artificial intelligence and automation comes with associated training and investment costs.
Market Opportunities: Government initiatives to strengthen analytical testing
Government initiatives to enhance analytical testing capabilities offer growth opportunities in the pharmaceutical analytical testing market. For instance, according to the WHO, around 349 vaccines were in development as of April 15, 2022. This is anticipated to drive up the demand for analytical testing services for COVID-19 vaccines that are undergoing clinical trials. Johnson & Johnson tested Ad26.COV2.S, an investigational COVID-19 vaccine candidate, with support from Eurofins Scientific.
Pharmaceutical Analytical Testing Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients